Idiopathic intracranial hypertension: adult versus pediatric patients
DOI:
https://doi.org/10.12809/hkjo-v22n1p9-17Keywords:
Headache, Idiopathic intracranial hypertension with papilledema, Obesity, Pseudotumor cerebriAbstract
Idiopathic intracranial hypertension (IIH), also known as benign intracranial hypertension or pseudotumor cerebri, is characterized by increased intracranial pressure secondary to unknown causes. IIH affects both adults and children but predominately young obese females of child-bearing age. IIH gives rise to headache, visual disturbances, and symptoms of raised intracranial pressure. The pathophysiology of IIH remains elusive; postulations include obesity-related hormonal changes, obstruction of the central venous sinus, and hereditary causes. Diagnosing IIH is based on modified Dandy criteria. Diagnosis in children is challenging as symptoms and presentations vary; atypical and delayed presentations are not uncommon. Treatment for IIH includes oral acetazolamide or lumbar puncture; surgical treatment with shunts and optic nerve sheath fenestration is reserved for complicated and recurring cases. Treatment options for children are limited and associated with considerable risks and side effects. Vision loss is debilitating and occurs in 10% of IIH patients. A thorough and collaborative approach in managing IIH is needed. This study reviews the epidemiology, clinical presentation, diagnosis, and management of IIH in adults and pediatric patients.
References
Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2012;83:488-94. DOI: https://doi.org/10.1136/jnnp-2011-302029
Raoof N, Sharrack B, Pepper IM, Hickman SJ. The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol. 2011;18:1266-8. DOI: https://doi.org/10.1111/j.1468-1331.2011.03372.x
Yabe I, Moriwaka F, Notoya A, Ohtaki M, Tashiro K. Incidence of idiopathic intracranial hypertension in Hokkaido, the northernmost island of Japan. J Neurol. 2000;247:474-5. DOI: https://doi.org/10.1007/s004150070182
Liu IH, Wang AG, Yen MY. Idiopathic intracranial hypertension: clinical features in Chinese patients. Jpn J Ophthalmol. 2011;55:138-42. DOI: https://doi.org/10.1007/s10384-010-0907-9
Daniels AB, Liu GT, Volpe NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007;143:635-41. DOI: https://doi.org/10.1016/j.ajo.2006.12.040
Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology. 2009;72:304-9. DOI: https://doi.org/10.1212/01.wnl.0000333254.84120.f5
Mrejen S, Vignal C, Bruce BB, et al. Idiopathic intracranial hypertension: a comparison between French and North-American white patients. Rev Neurol (Paris). 2009;165:542-8. DOI: https://doi.org/10.1016/j.neurol.2008.11.021
Kim TW, Choung HK, Khwarg SI, Hwang JM, Yang HJ. Obesity may not be a risk factor for idiopathic intracranial hypertension in Asians. Eur J Neurol. 2008;15:876-9. DOI: https://doi.org/10.1111/j.1468-1331.2008.02207.x
Ko MW, Liu GT. Pediatric idiopathic intracranial hypertension (pseudotumor cerebri). Horm Res Paediatr. 2010;74:381-9. DOI: https://doi.org/10.1159/000321180
Lau WL, Ko CH, Cheng WW, Yau SK, Lee CY. Idiopathic intracranial hypertension in children: case report and estimation of local incidence. Hong Kong J Paediatr (new series). 2014;19:28-31.
Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neurol Sci. 1997;24:219-21. DOI: https://doi.org/10.1017/S031716710002182X
Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol.
;127:178-82.
Sheldon CA, Paley GL, Xiao R, et al. Pediatric idiopathic intracranial hypertension: age, gender, and anthropometric features at diagnosis in a large, retrospective, multisite cohort. Ophthalmology. 2016;123:2424-31. DOI: https://doi.org/10.1016/j.ophtha.2016.08.004
Kristensen B, Malm J, Markgren P, Ekstedt J. CSF hydrodynamics in superior sagittal sinus thrombosis. J Neurol Neurosurg Psychiatry. 1992;55:287-93. DOI: https://doi.org/10.1136/jnnp.55.4.287
Warner JE, Larson AJ, Bhosale P, et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol. 2007;27:258-62. DOI: https://doi.org/10.1097/WNO.0b013e31815b9af0
Tabassi A, Salmasi AH, Jalali M. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology. 2005;64:1893-6. DOI: https://doi.org/10.1212/01.WNL.0000163556.31080.98
Libien J, Kupersmith MJ, Blaner W, et al. Role of vitamin A metabolism in IIH: results from the idiopathic intracranial hypertension treatment trial. J Neurol Sci. 2017;372:78-84. DOI: https://doi.org/10.1016/j.jns.2016.11.014
Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci. 2009;54:1847-56. DOI: https://doi.org/10.1007/s10620-008-0585-3
Ooi LY, Walker BR, Bodkin PA, Whittle IR. Idiopathic intracranial hypertension: can studies of obesity provide the key to understanding pathogenesis? Br J Neurosurg. 2008;22:187-94. DOI: https://doi.org/10.1080/02688690701827340
Libien J, Blaner WS. Retinol and retinol-binding protein in cerebrospinal fluid: can vitamin A take the “idiopathic†out of idiopathic intracranial hypertension? J Neuroophthalmol. 2007;27:253-7. DOI: https://doi.org/10.1097/WNO.0b013e31815c44bc
Rohr A, Bindeballe J, Riedel C, et al. The entire dural sinus tree is compressed in patients with idiopathic intracranial hypertension: a longitudinal, volumetric magnetic resonance imaging study. Neuroradiology. 2012;54:25-33. DOI: https://doi.org/10.1007/s00234-011-0850-6
Sander K, Poppert H, Etgen T, Hemmer B, Sander D. Dynamics of intracranial venous flow patterns in patients with idiopathic intracranial hypertension. Eur Neurol. 2011;66:334-8. DOI: https://doi.org/10.1159/000331002
Bateman GA, Stevens SA, Stimpson J. A mathematical model of idiopathic intracranial hypertension incorporating increased arterial inflow and variable venous outflow collapsibility. J Neurosurg. 2009;110:446-56. DOI: https://doi.org/10.3171/2008.6.17609
Strydom MA, Briers N, Bosman MC, Steyn S. The anatomical basis of venographic filling defects of the transverse sinus. Clin Anat. 2010;23:153-9. DOI: https://doi.org/10.1002/ca.20911
Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003;60:1418-24. DOI: https://doi.org/10.1212/01.WNL.0000066683.34093.E2
Albuquerque FC, Dashti SR, Hu YC, et al. Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results. World
Neurosurg. 2011;75:648-55.
Chiu AM, Chuenkongkaew WL, Cornblath WT, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol. 1998;126:116-21. DOI: https://doi.org/10.1016/S0002-9394(98)00063-4
Kesler A, Goldhammer Y, Hadayer A, Pianka P. The outcome of pseudotumor cerebri induced by tetracycline therapy. Acta Neurol Scand. 2004;110:408-11. DOI: https://doi.org/10.1111/j.1600-0404.2004.00327.x
Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6:29-37. DOI: https://doi.org/10.2165/00128071-200506010-00004
Ekizoglu E, Icoz S, Tuzun E, et al. Aquaporin-4 antibodies are not present in patients with idiopathic intracranial hypertension. Cephalalgia. 2012;32:198-202. DOI: https://doi.org/10.1177/0333102411434167
Sinclair AJ, Viant MR, Ball AK, et al. NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases--a diagnostic tool? NMR Biomed. 2010;23:123-32. DOI: https://doi.org/10.1002/nbm.1428
Babikian P, Corbett J, Bell W. Idiopathic intracranial hypertension in children: the Iowa experience. J Child Neurol. 1994;9:144-9. DOI: https://doi.org/10.1177/088307389400900208
Phillips PH, Repka MX, Lambert SR. Pseudotumor cerebri in children. J AAPOS. 1998;2:33-8. DOI: https://doi.org/10.1016/S1091-8531(98)90107-0
Soler D, Cox T, Bullock P, Calver DM, Robinson RO. Diagnosis and management of benign intracranial hypertension. Arch Dis Child. 1998;78:89-94. DOI: https://doi.org/10.1136/adc.78.1.89
Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014;71:693-701. DOI: https://doi.org/10.1001/jamaneurol.2014.133
Bjorner JB, Kosinski M, Ware JE Jr. Using item response theory to calibrate the Headache Impact Test (HIT) to the metric of traditional headache scales. Qual Life Res. 2003;12:981-1002. DOI: https://doi.org/10.1023/A:1026123400242
Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item shortform survey for measuring headache impact: the HIT-6. Qual Life Res. 2003;12:963-74. DOI: https://doi.org/10.1023/A:1026119331193
Salman MS, Kirkham FJ, MacGregor DL. Idiopathic “benign†intracranial hypertension: case series and review. J Child Neurol. 2001;16:465-70. DOI: https://doi.org/10.1177/088307380101600701
Pollak L, Zohar E, Glovinsky Y, Huna-Baron R. Reevaluation of presentation and course of idiopathic intracranial hypertension--a large cohort comprehensive study. Acta Neurol Scand. 2013;127:406-12. DOI: https://doi.org/10.1111/ane.12060
Fraser C, Plant GT. The syndrome of pseudotumour cerebri and idiopathic intracranial hypertension. Curr Opin Neurol. 2011;24:12-7. DOI: https://doi.org/10.1097/WCO.0b013e328341f94a
Randhawa S, Van Stavern GP. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Opin Ophthalmol. 2008;19:445-53. DOI: https://doi.org/10.1097/ICU.0b013e3283112d3e
Bidot S, Bruce BB, Saindane AM, Newman NJ, Biousse V. Asymmetric papilledema in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35:31-6. DOI: https://doi.org/10.1097/WNO.0000000000000205
Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991;114:155-80.
Frisén L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry. 1982;45:13-8. DOI: https://doi.org/10.1136/jnnp.45.1.13
Yau GS, Lee JW, Chan TT, Yuen CY. Unilateral papilledema and choroidal folds: an uncommon presentation of idiopathic intracranial hypertension. Surgery Curr Res. 2014;4:193.
Beri S, Gosalakkal JA, Hussain N, Balky AP, Parepalli S. Idiopathic intracranial hypertension without papilledema. Pediatr Neurol. 2010;42:56-8. DOI: https://doi.org/10.1016/j.pediatrneurol.2009.07.021
Skau M, Milea D, Sander B, Wegener M, Jensen R. OCT for optic disc evaluation in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol. 2011;249:723-30. DOI: https://doi.org/10.1007/s00417-010-1527-2
NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311:1641-51. DOI: https://doi.org/10.1001/jama.2014.3312
Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci. 1993;116:18-28. DOI: https://doi.org/10.1016/0022-510X(93)90084-C
Rush JA. Pseudotumor cerebri: clinical profile and visual outcome in 63 patients. Mayo Clin Proc. 1980;55:541-6. DOI: https://doi.org/10.1016/S0025-6196(26)01332-7
Hershey AD, Powers SW, Winner P, Kabbouche MA. Pediatric Headaches in Clinical Practice. John Wiley & Sons; 2009. DOI: https://doi.org/10.1002/9780470740712
Suwanwela N, Phanthumchinda K, Kaoropthum S. Headache in brain tumor: a cross-sectional study. Headache. 1994;34:435-8. DOI: https://doi.org/10.1111/j.1526-4610.1994.hed3407435.x
Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol. 2002;17:745-8. DOI: https://doi.org/10.1177/08830738020170101401
Youroukos S, Psychou F, Fryssiras S, Paikos P, Nicolaidou P. Idiopathic intracranial hypertension in children. J Child Neurol. 2000;15:453-7. DOI: https://doi.org/10.1177/088307380001500706
Standridge SM. Idiopathic intracranial hypertension in children: a review and algorithm. Pediatr Neurol. 2010;43:377-90. DOI: https://doi.org/10.1016/j.pediatrneurol.2010.08.001
Digre KB, Nakamoto BK, Warner JE, Langeberg WJ, Baggaley SK, Katz BJ. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009;49:185-93. DOI: https://doi.org/10.1111/j.1526-4610.2008.01324.x
Suzuki H, Takanashi J, Kobayashi K, Nagasawa K, Tashima K, Kohno Y. MR imaging of idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 2001;22:196-9.
Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv Ophthalmol. 2007;52:597-617. DOI: https://doi.org/10.1016/j.survophthal.2007.08.018
Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492-5. DOI: https://doi.org/10.1212/01.WNL.0000029570.69134.1B
Friedman DI, Forman S, Levi L, Lavin PJ, Donahue S. Unusual ocular motility disturbances with increased intracranial pressure. Neurology. 1998;50:1893-6. DOI: https://doi.org/10.1212/WNL.50.6.1893
Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology. 1983;33:1386-8. DOI: https://doi.org/10.1212/WNL.33.10.1386
Digre KB, Corbett JJ. Idiopathic intracranial hypertension (pseudotumor cerebri): a reappraisal. Neurologist. 2001;7:2-67. DOI: https://doi.org/10.1097/00127893-200107010-00002
Sklar FH, Beyer CW Jr, Ramanathan M, Cooper PR, Clark WK. Cerebrospinal fluid dynamics in patients with pseudotumor cerebri. Neurosurgery. 1979;5:208-16. DOI: https://doi.org/10.1227/00006123-197908000-00003
Agid R, Farb RI, Willinsky RA, Mikulis DJ, Tomlinson G. Idiopathic intracranial hypertension: the validity of crosssectional neuroimaging signs. Neuroradiology. 2006;48:521-7. DOI: https://doi.org/10.1007/s00234-006-0095-y
Lee AG, Brazis PW. Magnetic resonance venography in idiopathic pseudotumor cerebri. J Neuroophthalmol. 2000;20:12-3. DOI: https://doi.org/10.1097/00041327-200020010-00004
Sylaja PN, Ahsan Moosa NV, Radhakrishnan K, Sankara Sarma P, Pradeep Kumar S. Differential diagnosis of patients with intracranial sinus venous thrombosis related isolated intracranial hypertension from those with idiopathic intracranial hypertension. J Neurol Sci. 2003;215:9-12. DOI: https://doi.org/10.1016/S0022-510X(03)00182-5
Leker RR, Steiner I. Features of dural sinus thrombosis simulating pseudotumor cerebri. Eur J Neurol. 1999;6:601-4. DOI: https://doi.org/10.1046/j.1468-1331.1999.650601.x
Kotagal S. Increased Intracanial Pressure. In: Swaiman KF, Ashwal S, Ferriero DM, editors. Pediatric Neurology: Principles and Practice. Mosby Elsevier; 1999.
Welch K. The intracranial pressure in infants. J Neurosurg. 1980;52:693-9. DOI: https://doi.org/10.3171/jns.1980.52.5.0693
Lyons MK, Meyer FB. Cerebrospinal fluid physiology and the management of increased intracranial pressure. Mayo Clin Proc. 1990;65:684-707. DOI: https://doi.org/10.1016/S0025-6196(12)65131-3
Johnston L, Paterson A. Benign intracranial hypertension. I. Diagnosis and prognosis. Brain. 1974;97:289-300. DOI: https://doi.org/10.1093/brain/97.1.289
Skau M, Brennum J, Gjerris F, Jensen R. What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia. 2006;26:384-99. DOI: https://doi.org/10.1111/j.1468-2982.2005.01055.x
Wechsler B, Vidailhet M, Piette JC, et al. Cerebral venous thrombosis in Behcet’s disease: clinical study and long-term follow-up of 25 cases. Neurology. 1992;42:614-8. DOI: https://doi.org/10.1212/WNL.42.3.614
Vachvanichsanong P, Dissaneewate P. Childhood systemic lupus erythematosus in Songklanagarind Hospital: a potential unique subgroup. Clin Rheumatol. 1993;12:346-9. DOI: https://doi.org/10.1007/BF02231576
Padhye LV, Van Stavern GP, Sharma A, Viets R, Huecker JB, Gordon MO. Association between visual parameters and neuroimaging features of idiopathic intracranial hypertension. J Neurol Sci. 2013;332:80-5. DOI: https://doi.org/10.1016/j.jns.2013.06.022
Wong R, Madill SA, Pandey P, Riordan-Eva P. Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol. 2007;7:15. DOI: https://doi.org/10.1186/1471-2415-7-15
Fridley J, Foroozan R, Sherman V, Brandt ML, Yoshor D. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg. 2011;114:34-9. DOI: https://doi.org/10.3171/2009.12.JNS09953
De Simone R, Marano E, Fiorillo C, et al. Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci. 2005;25:342-4. DOI: https://doi.org/10.1007/s10072-004-0368-3
Gücer G, Viernstein L. Long-term intracranial pressure recording in the management of pseudotumor cerebri. J Neurosurg. 1978;49:256-63. DOI: https://doi.org/10.3171/jns.1978.49.2.0256
Baker RS, Baumann RJ, Buncic JR. Idiopathic intracranial hypertension (pseudotumor cerebri) in pediatric patients. Pediatr Neurol. 1989;5:5-11. DOI: https://doi.org/10.1016/0887-8994(89)90002-7
Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol. 1994;9:130-4. DOI: https://doi.org/10.1177/088307389400900205
Distelmaier F, Sengler U, Messing-Juenger M, Assmann B, Mayatepek E, Rosenbaum T. Pseudotumor cerebri as an important differential diagnosis of papilledema in children. Brain Dev. 2006;28:190-5. DOI: https://doi.org/10.1016/j.braindev.2005.07.003
Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin. 2014;32:363-96. DOI: https://doi.org/10.1016/j.ncl.2014.01.001
Liu GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol. 1994;118:88-96. DOI: https://doi.org/10.1016/S0002-9394(14)72847-8
Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology. 2007;68:229-32. DOI: https://doi.org/10.1212/01.wnl.0000251312.19452.ec
Thenuwara K, Todd MM, Brian JE Jr. Effect of mannitol and furosemide on plasma osmolality and brain water. Anesthesiology. 2002;96:416-21. DOI: https://doi.org/10.1097/00000542-200202000-00029
Panagopoulos GN, Deftereos SN, Tagaris GA, et al. Octreotide: a therapeutic option for idiopathic intracranial hypertension. Neurol Neurophysiol Neurosci. 2007;1.
Çelebisoy N, Gökçay F, Şirin H, Akyürekli Ö. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116:322-7. DOI: https://doi.org/10.1111/j.1600-0404.2007.00905.x
Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuroophthalmol. 2004;24:138-45. DOI: https://doi.org/10.1097/00041327-200406000-00009
Casteels-Van Daele M, Van Geet C, Wouters C, Eggermont E. Reye syndrome revisited: a descriptive term covering a group of heterogeneous disorders. Eur J Pediatr. 2000;159:641-8. DOI: https://doi.org/10.1007/PL00008399
Acheson JF, Green WT, Sanders MD. Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosurg Psychiatry. 1994;57:1426-9. DOI: https://doi.org/10.1136/jnnp.57.11.1426
Goh KY, Schatz NJ, Glaser JS. Optic nerve sheath fenestration for pseudotumor cerebri. J Neuroophthalmol. 1997;17:86-91. DOI: https://doi.org/10.1097/00041327-199706000-00003
Mauriello JA Jr, Shaderowfsky P, Gizzi M, Frohman L. Management of visual loss after optic nerve sheath decompression in patients with pseudotumor cerebri.Ophthalmology. 1995;102:441-5. DOI: https://doi.org/10.1016/S0161-6420(95)31002-0
Kelman SE, Heaps R, Wolf A, Elman MJ. Optic nerve decompression surgery improves visual function in patients with pseudotumor cerebri. Neurosurgery. 1992;30:391-5. DOI: https://doi.org/10.1097/00006123-199203000-00013
Lee AG, Patrinely JR, Edmond JC. Optic nerve sheath decompression in pediatric pseudotumor cerebri. Ophthalmic Surg Lasers. 1998;29:514-7. DOI: https://doi.org/10.3928/1542-8877-19980601-15
Spoor TC, McHenry JG, Shin DH. Long-term results using adjunctive mitomycin C in optic nerve sheath decompression for pseudotumor cerebri. Ophthalmology. 1995;102:2024-8. DOI: https://doi.org/10.1016/S0161-6420(95)30759-2
Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol. 1993;111:632-5. DOI: https://doi.org/10.1001/archopht.1993.01090050066030
Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996;46:1524-30. DOI: https://doi.org/10.1212/WNL.46.6.1524
Bynke G, Zemack G, Bynke H, Romner B. Ventriculoperitoneal shunting for idiopathic intracranial hypertension. Neurology. 2004;63:1314-6. DOI: https://doi.org/10.1212/01.WNL.0000140699.43019.48
Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997;49:734-9. DOI: https://doi.org/10.1212/WNL.49.3.734
Abubaker K, Ali Z, Raza K, Bolger C, Rawluk D, O’Brien D. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts--case series and literature review. Br J Neurosurg. 2011;25:94-9. DOI: https://doi.org/10.3109/02688697.2010.544781
Ahmed RM, Wilkinson M, Parker GD, et al. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol. 2011;32:1408-14. DOI: https://doi.org/10.3174/ajnr.A2575
Thurtell MJ, Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr Treat Options Neurol. 2013;15:1-12. DOI: https://doi.org/10.1007/s11940-012-0207-4
Wall M, George D. Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy. Arch Neurol. 1987;44:170-5. DOI: https://doi.org/10.1001/archneur.1987.00520140040015
Chumas PD, Kulkarni AV, Drake JM, Hoffman HJ, Humphreys RP, Rutka JT. Lumboperitoneal shunting: a retrospective study in the pediatric population. Neurosurgery. 1993;32:376-83. DOI: https://doi.org/10.1097/00006123-199303000-00007
Baheti NN, Nair M, Thomas SV. Long-term visual outcome in idiopathic intracranial hypertension. Ann Indian Acad Neurol. 2011;14:19-22. DOI: https://doi.org/10.4103/0972-2327.78044
Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O’Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol. 1993;50:78-80. DOI: https://doi.org/10.1001/archneur.1993.00540010072020
Best J, Silvestri G, Burton B, Foot B, Acheson J. The incidence of blindness due to idiopathic intracranial hypertension in the UK. Open Ophthalmol J. 2013;7:26-9. DOI: https://doi.org/10.2174/1874364101307010026
Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: a casecontrol study. Neurology. 2011;76:1564-7. DOI: https://doi.org/10.1212/WNL.0b013e3182190f51
Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39:461-74. DOI: https://doi.org/10.1001/archneur.1982.00510200003001
Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology. 2002;58:1551-3. DOI: https://doi.org/10.1212/WNL.58.10.1551
Weisberg LA. Benign intracranial hypertension. Medicine (Baltimore). 1975;54:197-207. DOI: https://doi.org/10.1097/00005792-197505000-00002
Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology. 2004;63:1737-9. DOI: https://doi.org/10.1212/01.WNL.0000143067.40281.16
Szewka AJ, Bruce BB, Newman NJ, Biousse V. Idiopathic intracranial hypertension: relation between obesity and visual outcomes. J Neuroophthalmol. 2013;33:4-8. DOI: https://doi.org/10.1097/WNO.0b013e31823f852d
Stiebel-Kalish H, Serov I, Sella R, Chodick G, Snir M. Childhood overweight or obesity increases the risk of IIH recurrence fivefold. Int J Obes (Lond). 2014;38:1475-7. DOI: https://doi.org/10.1038/ijo.2014.44
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Hong Kong Journal of Ophthalmology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal has a fully Open Access policy and publishes all articles under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. For any use other than that permitted by this license, written permission must be obtained from the Journal.
